Croaking

$CING - Low Float - Positive Top Line Results - ADHD 1 PILL

做多
Croaking 已更新   
NASDAQ:CING   Cingulate Inc.
We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
评论:
Curious what this would mean for the current producers of such meds like JNJ , PFE , NVS ? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。